CD8+, CD3+, CD45RO+ memory T cells, and tumor-infiltrating lymphocytes (TILs) are widely confirmed as representative potential powerful prognostic instruments for many solid tumors, including NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.